Company: KD
Filing Date: 2025-06-16
Form Type: DEF 14A
Source: 0001140361-25-022676
Chunk: 8

Company: Kyndryl Holdings, Inc.
Filing Date: 2025-06-16
Form: DEF 14A
Chunk 8
---
 officer of Dow Inc., DowDuPont and The Dow Chemical Company                                                                                         
 •Managed the financial complexities of the historic merge-and-spin of DowDuPont, an $86 billion holding company comprised of The Dow Chemical Company and DuPont from September 2017 to April 2019 
 •Financial leadership for The Dow Chemical Company’s strategic ownership restructuring of its Dow Corning Corporation silicones business joint venture completed in 2016                           
 •Affiliation with leading business and public policy associations as the immediate past Chair of the Business Leaders for Michigan business roundtable                                             
 •Outside board experience as a director of American Airlines Group Inc.                                                                                                                            |     | Relevant Experience                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 Mr. Ungerleider served as a public company chief financial officer for a decade, beginning with The Dow Chemical Company from 2014 to 2015. He then became the chief financial officer of DowDuPont effective upon the merger of The Dow Chemical Company and E.I. du Pont de Nemours and Company, a role he held until 2019 when Dow Inc. separated from DowDuPont. Mr. Ungerleider then served as chief financial officer of Dow Inc. through 2023. He also served as president of Dow Inc. from 2019 through 2023, before retiring from the company in January 2024. 
 In January 2024, Mr. Ungerleider was appointed as an Operating Advisor to Clayton, Dubilier & Rice funds.                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 Mr. Ungerleider previously served as chairman of the Dow Company Foundation. He currently serves on the Board of Directors of American Airlines Group Inc. He also serves on the Board of Directors of the Rollin M. Gerstacker Foundation and the Michigan Baseball Foundation. Mr. Ungerleider is the immediate past Chair of the Business Leaders for Michigan business roundtable.                                                                                                                                                                                  |

| 10|KYNDRYL2025 PROXY STATEMENT |

TABLE OF CONTENTS

CLASS III DIRECTORS, WITH TERMS EXPIRING AT THE 2027 ANNUAL MEETING

| DOMINIC J. CARUSO                                             |     | INDEPENDENT DIRECTOR since 2021                                                                                                                                 |     | AGE 67                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Retired Executive Vice President and Chief Financial Officer, 
 Johnson & Johnson,a global healthcare products company        
 COMMITTEE: Audit                                              
 (Chair)                                                       |     | Qualifications, Attributes and Skills                                                                                                                           
 •Global business experience as former chief financial officer of